Direct integration with our certified food-grade manufacturing infrastructure. Audited for potency, purity, and trace-contaminant prevention.
Lactobacillus reuteri (recently classified phylogenetically as Limosilactobacillus reuteri) represents one of the most therapeutically prominent, heterofermentative lactic acid bacteria indigenous to the mammalian gastrointestinal tract. Unlike standard commensal strains that merely pass through the intestinal lumen passively, Food Grade Lactobacillus reuteri synthesizes potent antimicrobial secondary metabolites—notably reuterin (3-hydroxypropionaldehyde, or 3-HPA), cobalamin (Vitamin B12), and conjugated linoleic acids (CLA). These functional compounds provide targeted physiological advantages ranging from the competitive inhibition of pathogenic enterobacteria to significant anti-inflammatory cytokine modulation via the gut-brain and gut-skin axis.
Endogenous secretion of broad-spectrum Reuterin disrupts DNA synthesis and protein function in target pathogens such as Escherichia coli, Salmonella enterica, and Candida albicans without destroying systemic commensal gut flora.
Every master cell bank is indexed with whole-genome sequencing (WGS). We ensure precise identity verification down to strain-level fingerprinting, rigorously verifying the total absence of plasmid-borne antibiotic resistance genes (AMR).
Engineered via adaptive laboratory evolution and multi-stage cryoprotective encapsulation, our bulk powders maintain standard colony-forming units (CFU) through low-pH gastric conditions and industrial manufacturing friction.
International enterprise buyers—encompassing brand owners in North America, pharmaceutical and supplement innovators in the European Union, and rapidly expanding nutritional functional brands throughout Southeast Asia—are transitioning from purchasing uncharacterized "lactic cultures" to demanding strictly characterized functional biomass. Sourcing managers now require documented biological safety, validated shelf-life stability models, and deep regulatory conformance.
Strict compliance with US FDA GRAS (Generally Recognized as Safe), European EFSA QPS (Qualified Presumption of Safety), and clean-label non-GMO status. Full audit dossiers detailing strain history, genomic stability, and safety testing are provided to expedite enterprise product registration.
Procurement demands are shifting from dilute blends to high-density pure cultures ranging from 100 Billion (1.00×10¹¹) to 500 Billion (5.00×10¹¹) CFU/g. This allows formulators minimal fill weights in complex multi-strain capsules, sticks, and suspension droplets without compromising potency.
Bulk buyers require empirical degradation kinetic models rather than theoretical claims. Our testing protocols provide 24-month stability data under standard storage conditions (2–8°C) as well as accelerated room temperature (25°C/60% RH) challenges for stable global distribution.
Our state-of-the-art bio-manufacturing facility bridges biological discovery with large-scale industrial output. Harnessing Industry 4.0 automation, advanced deep-tank submerged anaerobic fermentation, and specialized downstream harvesting, we resolve historical industry bottlenecks: cell-wall shearing, metabolic inactivation, and batch-to-batch yield divergence.
Fully integrated Distributed Control Systems (DCS) regulate pH, dissolved oxygen, nutrient feeding matrices, and metabolic byproduct accumulation in real-time, preventing bacterial stress during log-phase growth.
Our proprietary three-tier cellular coating shields live cells within a natural polysaccharide-protein matrix, protecting the bacterial envelope through mechanical blending and high-acid physiological exposure.
Utilizing freeze-drying sublimative drying systems, we minimize crystal rupture across cell walls, maintaining stable cell membranes and achieving shelf viability unachievable via generic spray drying.
Our Food Grade Lactobacillus reuteri powder is tailored for cross-industry compatibility. With balanced dispersibility, stable flowability, and clean sensory properties, it integrates reliably into diverse delivery formats.
Clinically supported for infant drop suspensions and follow-on formulas. It aids in the relief of infant colic, decreases excessive crying durations, and supports balance in nascent pediatric digestive flora.
Ideal for direct-dissolve lozenges and chewables. It binds effectively to oral epithelial surfaces, selectively outcompeting cariogenic Streptococcus mutans and supporting periodontal integrity.
Standardized for fermentation stability in yogurts, fermented plant bases, and non-dairy probiotic beverages, offering balanced acidity balance without post-acidification off-flavors.
Complementary ingredients tested for purity, assay value, and formulation compatibility.
Direct responses to quality control, formulation viability, and logistics queries from technical directors and raw material sourcing heads.